Here we describe two cases of mucosa-associated lymphoid tissue (MALT) lymphoma with monoclonal immunoglobulins (Igs). The first case was a 77-year-old man with primary lymphoma of the lung. Immunoelectrophoresis detected IgM-κ in serum and κ light chain excretion into urine. Three months after treatment with single-agent rituximab, a large amount of pleural fluid was found to have accumulated. The fluid contained CD5 -, CD10 -, CD19
INTRODUCTION
Monoclonal immunoglobulin (Ig) in the serum and/or urine can be detected in a variety of mature B-cell-type lymphoproliferative disorders, including extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). 1 MALT lymphoma tissues contain not only "centrocyte-like" cells but also plasmacytoid cells with varying degrees of maturation, 2 which may explain the high incidence of monoclonal gammopathy in this particular subtype of low grade B-cell tumors. 3, 4 On the other hand, several cases have been reported to exhibit features overlapping with primary macroglobulinemia, [5] [6] [7] [8] [9] [10] supporting further that neoplastic cells in MALT lymphomas have the potential to differentiate into Ig-secreting plasma cells.
Rituximab, a human-mouse chimeric monoclonal antibody against CD20 antigen, has been used in patients with Bcell tumors in a number of clinical settings. 11 Although controlled trials to define the optimal therapy for MALT lymphoma have not been published, rituximab alone has some activity against both untreated and relapsed MALT lymphoma, irrespective of the stage or primary site. [12] [13] [14] In this report, we describe two cases of advanced-stage MALT lymphoma associated with monoclonal gammopathy. While the disease appeared initially to respond to single-agent rituximab or rituximab-containing chemotherapy, the levels of monoclonal Ig in the serum were not significantly altered by treatment. This case report also suggests a potential mechanism for the resistance of MALT lymphoma to rituximab.
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CASE REPORT
Case 1
The patient was a 77-year-old man who presented to our hospital with shortness of breath. Chest radiography and computed tomography (CT) revealed irregular opacities, consisting of confluent tumor masses and interstitial infiltrates occupying the middle fields of both lungs. Combined positron-emission tomography (PET) and CT demonstrated intense accumulation of fluorodeoxyglucose (FDG) within these complicated lung lesions (Fig. 1a) . No extra-thoracic lesions were detected.
Three years prior to presentation, the patient had undergone bronchoscopic examination for the lung lesions at another hospital. Histological specimens prepared from the bronchoalveolar lavage fluid detected the accumulation of small lymphoma cells that stained with an anti-CD20 monoclonal antibody. The patient was diagnosed with a low-grade lymphoma of "bronchus-associated lymphoid tissue" ; at that time, however, he declined treatment for the disease.
Blood cell counts and routine blood chemistry were normal, with the exception of an M-spike on protein electrophoresis. Serum contained 95 mg/dL IgA, 433 mg/dL IgG, and 2,022 mg/dL IgM. Immunoelectrophoresis confirmed that the monoclonal Ig in the serum was labeled with IgM and κ-chain anti-sera ; κ light chain was detected in urine. Immunophenotyping of the peripheral blood and bone marrow by flow cytometry revealed a monoclonal B-cell population expressing surface-membrane (Sm) IgM-κ . The serum level of soluble interleukin-2 receptor (sIL-2R) was 8,925 IU/mL.
After informing the patient of the potential treatment options for disseminated low-grade B-cell lymphoma, he gave consent to be treated with single-agent rituximab. In response to four weekly doses of 375 mg/m 2 rituximab, the lung lesions appeared to regress ; his respiratory symptoms resolved (Fig.  2a) . Three months after treatment, however, he developed dyspnea. A chest radiograph indicated marked progression of the right pleural effusion. Serum levels of sIL-2R and monoclonal Ig increased concurrently (Fig. 2a) . The pleural fluid contained large numbers of lymphoma cells with a lymphoplasmacytoid appearance (Fig. 3a) . Occasional large and/or bi-nucleated cells were present. Flow cytometry revealed a surface phenotype of CD5 -, CD10 -, CD19 + , CD38 + and CD138 -/+ (Fig. 3b) . Although a small fraction of the cells were CD20 + , the lymphoma cells were primarily CD20 -, expressing low levels of SmIgM-κ (Fig. 3b) . The G-banded karyotype of the pleural fluid cells was : 46, XY, t(11;18) (q21;q21) [12] /46, XY [8] .
The fluid contained monoclonal Ig identical to that found in serum ; the levels of Ig were 43 mg/dL IgA, 195 mg/dL IgG, and 1,500 mg/dL IgM. The concentration of lactate dehydrogenase was 2,870 IU/L. After removal of the pleural effusion, the patient's respiratory symptoms improved. The patient declined further treatment for lymphoma, but has been followed up regularly as an outpatient.
Case 2
A 55-year-old man was admitted to our hospital with perforation of the gastrointestinal tract. Five years prior to admission, the patient had presented to another hospital with anorexia and weight loss ; endoscopic examination had revealed gastric MALT lymphoma. His symptoms improved in response to antibiotic therapy for eradication of Helicobacter pylori (H. pylori). The patient had remained well until the day before admission, when he developed sudden-onset, severe, diffuse abdominal pain.
A CT scanning of the abdomen taken at admission revealed free air anterior to the left lobe of the liver, thickening of the gastric wall, and para-aortic lymphadenopathy. Immediate laparotomy was performed, revealing a perforation at the anterior wall of the mid-body of the stomach ; this lesion was closed with a piece of greater omentum. Endoscopic examination after surgery demonstrated erosions of the mucosa from the fundus to the pre-pylorus and a cobble-stone appearance of the mid-body. Biopsies revealed a non-diagnostic lymphocytic infiltrate. Bacterial cultures for H. pylori were negative. A PET scan indicated increased FDG uptake in the gastric wall and lymph nodes of the mediastinum and the lung hilum (Fig. 1b) .
The patient subsequently underwent subtotal gastrectomy due to concerns that future cytotoxic therapy would lead to gastric perforation and/or bleeding. Microscopic examination of the excised stomach revealed transmural infiltrates of small lymphoid cells, extending from the mucosa (Fig. 4a) to the serosa (Fig. 4b) . Cells within the subepithelial areas, which exhibited a plasmacytoid appearance, had invaded the gastric glands, generating lymphoepithelial lesions ( Fig. 4c and 4d) . Regional lymph nodes displayed a nodular architecture with expansion of the marginal zone, containing small cells and scattered large cells (Fig. 4e and 4f ) expressing CD20 and Bcl-2 ( Fig. 4g and 4h) . Outside of these nodules, we observed cytological heterogeneity ; immunoblast-like cells and plasma cells aggregated within the sinusoids (Fig. 4i) .
We prepared a single cell suspension from a lymph node and subjected these cells to flow cytometry. Lymphoma cells expressed CD19, CD20, and either SmIgM or SmIgA in association with κ light chain, but lacked CD5 and CD10 expression. No plasma cell fraction was detected in this study. Thirteen of 14 metaphases had a karyotype of 46, XY, t(11; 18)(q21;q21) ; fluorescence in situ hybridization (FISH) of interphase cells confirmed an alteration in the MALT1 gene. Both bone marrow and peripheral blood included a monoclonal B-cell population of the CD19 + , CD20 + , and SmIg κ + immunophenotype, as demonstrated by flow cytometry. Bone marrow smears revealed an increase in the lymphocyteplasma cell series, which comprised 13.0% of nucleated marrow cells.
Serum protein electrophoresis revealed an M-spike in the γ-globulin region ; immunoelectrophoresis detected an Mbow of IgA-κ , which also labeled with an IgM antiserum less intensely than IgA. We also identified the urinary excretion 
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of κ light chain. Serum contained 824 mg/dL IgA, 1,209 mg/dL IgG, and 119 mg/dL IgM. The levels of sIL-2R before and after surgery were 2,026 and 1,082 U/mL, respectively.
We made a diagnosis of disseminated gastric MALT lymphoma. The patient was treated with R-CVP (rituximab 375 mg/m 2 on day 1, cyclophosphamide 750 mg/m 2 on day 3, vincristine 1.4 mg/m 2 on day 3, and prednisolone 100 mg on days 3 through 7) combination therapy every three weeks (Fig. 2b) . During the treatment course, the para-aortic lymph nodes and spleen decreased in size, and sIL-2R levels normalized. The M-spike detected by protein electrophoresis and the serum IgA levels, however, were not significantly af- Fig. 4 . Histopathology of excised stomach (4a through 4d) and a gastric lymph node (4e through 4i). Staining and magnification with an objective lens : 4a, HE, x20 ; 4b, HE, x10 ; 4c, HE, x40 ; 4d, HE, x100 ; 4e, HE, x20 ; 4f, HE, x40 ; 4g, anti-CD20 immunostaining, x40 ; 4h, anti-Bcl-2 immunostaining, x40 ; and 4i, HE, x100.
